Fig. 2.
Fig. 2. The costimulatory capacity of blood derived CMRF-44 purified DC compared with CD14+ Mo and CD19+ B lymphocytes. (a) The flow cytometry labeling of Nycodenz low-density cells is shown before sorting CMRF-44+ CD14− DC and CMRF-44− CD14+ Mo. (b) Allogeneic T-lymphocyte proliferative responses measured with 3H thymidine, are shown using each FACS purified cell populations as stimulators.77 The allostimulatory capacity of sorted DC, Mo, and B lymphocytes (CD19+ sorted) are compared at a ratio of 1 APC to 50 allogeneic T lymphocytes. (c) DC and Mo are compared in their ability to process and present the soluble protein antigens to KLH and tetanus toxoid to autologous T lymphocytes at an APC:T lymphocyte ratio of 1:20.

The costimulatory capacity of blood derived CMRF-44 purified DC compared with CD14+ Mo and CD19+ B lymphocytes. (a) The flow cytometry labeling of Nycodenz low-density cells is shown before sorting CMRF-44+ CD14 DC and CMRF-44 CD14+ Mo. (b) Allogeneic T-lymphocyte proliferative responses measured with 3H thymidine, are shown using each FACS purified cell populations as stimulators.77 The allostimulatory capacity of sorted DC, Mo, and B lymphocytes (CD19+ sorted) are compared at a ratio of 1 APC to 50 allogeneic T lymphocytes. (c) DC and Mo are compared in their ability to process and present the soluble protein antigens to KLH and tetanus toxoid to autologous T lymphocytes at an APC:T lymphocyte ratio of 1:20.

Close Modal

or Create an Account

Close Modal
Close Modal